Page last updated: 2024-10-24

bupivacaine and Reticulum Cell-Like Sarcoma, Yoshida

bupivacaine has been researched along with Reticulum Cell-Like Sarcoma, Yoshida in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ajiki, T1
Murakami, T1
Kobayashi, Y1
Hakamata, Y1
Wang, J1
Inoue, S1
Ohtsuki, M1
Nakagawa, H1
Kariya, Y1
Hoshino, Y1
Kobayashi, E1

Other Studies

1 other study available for bupivacaine and Reticulum Cell-Like Sarcoma, Yoshida

ArticleYear
Long-lasting gene expression by particle-mediated intramuscular transfection modified with bupivacaine: combinatorial gene therapy with IL-12 and IL-18 cDNA against rat sarcoma at a distant site.
    Cancer gene therapy, 2003, Volume: 10, Issue:4

    Topics: Anesthetics, Local; Animals; Biolistics; Bupivacaine; DNA, Complementary; Gene Expression; Genetic T

2003